Beta-adrenoceptor drugs and progression to Parkinson’s disease milestones in a large pooled incident cohort

Beta-adrenoceptor drugs and progression to Parkinson’s disease milestones in a large pooled incident cohort

Publication date: Jul 05, 2025

Publication: Nature -njp Parkinsons DiseaseRuwani S. Wijeyekoon, Marta Camacho, David Bckstrm, Lars Forsgren, Rachael A. Lawson, Alison J. Yarnall, Angus D. Macleod, Carl E. Counsell, Ole-Bjrn Tysnes, Guido Alves, Jodi Maple-Grdem, Roger A. Barker & Caroline H. Williams-Gray03 July 2025AbstractBeta-adrenoceptor-blockers and agonists have been associated with an increased and decreased risk of Park .. .

Concepts Keywords
2025abstractbeta Adrenoceptor
Dementia Agonist
Jodi Baseline
July Beta
Maple Blocker
Dementia
Drugs
Incident
Non
Parkinsons
Progressed
Progression
Users
Y3

Semantics

Type Source Name
disease MESH dementia
disease MESH Parkinson’s disease

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *